IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORETTI, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.702
EU - Europa 2.065
AS - Asia 720
SA - Sud America 15
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.515
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.698
UA - Ucraina 580
IE - Irlanda 439
SE - Svezia 323
SG - Singapore 284
IT - Italia 227
HK - Hong Kong 147
DE - Germania 136
CN - Cina 127
FI - Finlandia 120
VN - Vietnam 117
RU - Federazione Russa 89
FR - Francia 34
GB - Regno Unito 30
CZ - Repubblica Ceca 17
BR - Brasile 15
BE - Belgio 14
CH - Svizzera 14
KR - Corea 13
GR - Grecia 11
NL - Olanda 10
AT - Austria 8
CI - Costa d'Avorio 8
UZ - Uzbekistan 8
IN - India 6
LB - Libano 6
PL - Polonia 6
TR - Turchia 6
MX - Messico 4
EU - Europa 3
JP - Giappone 3
LT - Lituania 2
BG - Bulgaria 1
DK - Danimarca 1
IQ - Iraq 1
LK - Sri Lanka 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 5.515
Salva come PNG Salva come JPEG
Città #
Chandler 494
Dublin 439
San Mateo 271
Jacksonville 250
Singapore 224
Boardman 165
Hong Kong 147
Santa Clara 121
Dong Ket 116
Altamura 114
Medford 108
Princeton 108
Des Moines 102
Wilmington 92
Lawrence 86
Ann Arbor 72
Perugia 69
Andover 62
Beijing 52
Falls Church 47
Saint Petersburg 36
Norwalk 27
Dearborn 25
Woodbridge 22
Ashburn 21
New York 19
San Paolo di Civitate 19
Brussels 14
Brno 13
Helsinki 12
Munich 11
Fremont 9
Seoul 9
Shanghai 9
Abidjan 8
Cambridge 7
Dallas 7
Moscow 7
Den Haag 6
Auburn Hills 5
Izmir 5
Lausanne 5
Frankfurt Am Main 4
Houston 4
Nagpur 4
Nanjing 4
San Diego 4
Hanover 3
Hefei 3
Jinan 3
Kraków 3
Los Angeles 3
Nürnberg 3
Tappahannock 3
Chengdu 2
Chicago 2
Chongqing 2
Handan 2
Lappeenranta 2
Nanchang 2
Planegg 2
Pune 2
Rio De Janeiro 2
Shenyang 2
Shijiazhuang 2
Wako 2
Amsterdam 1
Athens 1
Baghdad 1
Boston 1
Brasília 1
Bratislava 1
Cagliari 1
Caldas Novas 1
Campo do Tenente 1
Caraúbas do Piauí 1
Cariacica 1
Copenhagen 1
Dalian 1
Dambulla 1
Denver 1
Edinburgh 1
Falkenstein 1
Foligno 1
Genova 1
Groningen 1
Guangzhou 1
Harbin 1
Itacaré 1
Kunming 1
Lagos 1
Lauro de Freitas 1
Libertyville 1
Lisbon 1
London 1
Ludwigshafen 1
Marcallo con Casone 1
Mexico City 1
Monmouth Junction 1
Monte Alto 1
Totale 3.534
Salva come PNG Salva come JPEG
Nome #
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 107
T cell apoptosis by kynurenines. 103
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 88
Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. 88
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 85
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 85
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 80
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 80
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 80
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 75
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 75
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 74
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 74
Antitumor activity of three nitrosourea analogues in different experimental tumor system 74
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 72
Modulation of tryptophan catabolism by regulatory T cells 70
Antigenic changes related to drug action. 69
Antilymphoma graft responses in the mouse brain: a study of T-dependent functions. 69
Dual effect of IL-4 on resistance to systemic gram-negative infection and production on TNF-alfa 68
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 67
3H-aniracetam binds to specific recognition sites in brain membranes 66
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 66
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 66
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. 66
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 64
Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. 63
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia. 63
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. 63
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 61
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 61
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 60
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 59
Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. 59
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 58
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 58
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 58
Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens. 58
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 56
T cell apoptosis by tryptophan catabolism 56
[In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC]. 56
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 56
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 55
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 55
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 55
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 55
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 54
CTLA-4-Ig regulates tryptophan catabolism in vivo. 52
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 52
Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotides. 52
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies. 52
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 52
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 51
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 51
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 51
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 51
Chemical xenogenization of tumor cells. 50
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. 50
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease 50
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 50
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 49
IL-9 protects mice from Fram-negative bacterial shock: suppression of alfa-TNF, IL-12 and gamma-IFN, and induction of IL-10. 48
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 48
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 47
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 47
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 47
Cytokines and tumours: problems and perspectives. 46
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 46
Regulation of tumor antigen expression by drugs acting as mutagens and/or gene activators. 45
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 45
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 44
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 43
I Chemioterapici 43
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 43
Molecular and genomic aspects of xenogenizing-alkylating drugs. 43
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 42
Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. 42
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 41
Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo. 41
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 41
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 41
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 40
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 40
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 40
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 40
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 39
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 39
Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative. 39
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 39
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 39
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 38
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 38
Rejectionof drug-treated tumor cells inthe peritoneal cavity of mice 38
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 38
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens. 37
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 37
Generation of monoclonal antibodies to a chemically xenogenized murine lymphoma. 36
Tryptophan catabolism in nonobese diabetic mice. 36
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 35
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives. 34
Rational bases of cancer immunochemotherapy: drug effects on antigen expression 34
Totale 5.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 0 0 3 100 48 8 57
2020/2021992 5 94 37 89 277 67 67 0 111 30 84 131
2021/2022961 15 168 9 56 73 27 16 302 18 29 74 174
2022/20231.664 128 295 15 124 145 247 1 87 556 5 47 14
2023/2024509 44 88 19 6 3 2 108 7 65 8 71 88
2024/2025544 21 125 77 42 195 61 11 12 0 0 0 0
Totale 5.699